CRISPR Therapeutics AG (LON: 0VRQ)

CRISPR Therapeutics AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,063	3,904	2,641	4,283	7,923	2,734
Market Cap Growth	5.04%	47.79%	-38.32%	-45.95%	189.80%	134.05%
Enterprise Value	1,676	2,728	1,205	2,605	6,959	2,290
Last Close Price	34.95	49.77	32.88	56.98	112.54	52.02
PE Ratio	-	-	-	15.36	-	54.16
PS Ratio	20.50	13.40	2656.64	6.34	15045.33	12.50
PB Ratio	2.14	2.64	1.70	2.42	6.50	3.85
P/TBV Ratio	2.14	2.64	1.70	2.42	6.50	3.86
P/FCF Ratio	-	-	-	12.68	-	72.43
P/OCF Ratio	-	-	-	10.76	-	63.89
EV/Sales Ratio	10.18	9.36	1211.76	3.86	13213.93	10.47
EV/EBITDA Ratio	-	-	-	9.01	-	58.93
EV/EBIT Ratio	-	-	-	9.44	-	64.89
EV/FCF Ratio	-11.75	-	-	7.71	-	60.67
Debt / Equity Ratio	0.12	0.13	0.13	0.09	0.04	0.06
Debt / EBITDA Ratio	-	-	-	0.53	-	0.77
Debt / FCF Ratio	-	-	-	0.49	-	1.05
Asset Turnover	0.09	0.17	0.00	0.40	0.00	0.37
Quick Ratio	21.55	17.47	15.08	19.92	18.05	17.17
Current Ratio	21.64	17.54	15.30	20.17	18.21	17.29
Return on Equity (ROE)	-13.07%	-8.17%	-30.42%	18.59%	-26.80%	10.04%
Return on Assets (ROA)	-9.57%	-6.22%	-16.85%	10.19%	-15.31%	3.76%
Return on Capital (ROIC)	-10.04%	-6.56%	-17.74%	10.73%	-16.30%	4.22%
Earnings Yield	-5.84%	-3.09%	-20.43%	6.51%	-3.22%	1.85%
FCF Yield	-4.66%	-5.43%	-16.74%	7.88%	-2.37%	1.38%
Buyback Yield / Dilution	-5.11%	-1.90%	3.29%	-21.90%	-15.84%	-18.70%
Total Shareholder Return	-5.11%	-1.90%	3.29%	-21.90%	-15.84%	-18.70%

Source: S&P Capital IQ. Standard template. Financial Sources.